David Liu (Photo by Jessica Rinaldi/The Boston Globe via Getty Images)

New David Liu study de­tails virus-like de­liv­ery sys­tem for prime edit­ing

Re­searchers led by gene edit­ing pi­o­neer David Liu have de­vel­oped an­oth­er way to de­liv­er prime ed­i­tors and shown that it can be used in mice to de­liv­er a gene edit­ing ther­a­py that par­tial­ly re­stores vi­sion.

The sci­en­tists en­gi­neered virus-like par­ti­cles, which they call eVLPs for short, to de­liv­er all the key parts need­ed for prime edit­ing, ac­cord­ing to the pa­per pub­lished in Na­ture Biotech­nol­o­gy. Virus-like par­ti­cles are com­plex­es made up of vi­ral pro­teins but lack vi­ral ge­net­ic ma­te­r­i­al, so they aren’t in­fec­tious.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.